A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments?
dc.contributor.author | Galletly, C. | |
dc.contributor.author | Gill, S. | |
dc.contributor.author | Clarke, P. | |
dc.contributor.author | Burton, C. | |
dc.contributor.author | Fitzgerald, P. | |
dc.date.issued | 2012 | |
dc.description.abstract | Background: Repetitive transcranial magnetic stimulation (rTMS) has been shown to be an effective treatment for depression. However, there has been little research to determine optimal parameters for treatment. Method: This study compared two rTMS treatment regimes for the treatment of major depression. Seventy-seven participants were randomized to either spaced or daily treatment. Spaced rTMS was given 3 days/week for 6 weeks (18 treatments in total) and daily rTMS was given 5 days/week for 4 weeks (20 treatments in total). All participants were assessed at baseline and after 4 weeks of treatment. Participants in the spaced treatment group were also assessed after 6 weeks of treatment. All participants were treated at 110% of the resting motor threshold with high-frequency rTMS (10 Hz) to the left dorsolateral prefrontal cortex (DLPFC) followed by low-frequency rTMS to the right DLPFC. Results: Participants in the daily treatment group showed more improvement by week 4 than those in the spaced treatment group; however, both groups had similar improvement by treatment completion. There was significant improvement in both groups in ratings of depression and anxiety, with no significant differences between groups. Conclusions: Our study indicates that the efficacy of rTMS is related to the number of treatments given and that spacing the treatments neither improves nor reduces efficacy. | |
dc.description.statementofresponsibility | C. Galletly, S. Gill, P. Clarke, C. Burton and P. B. Fitzgerald | |
dc.identifier.citation | Psychological Medicine, 2012; 42(5):981-988 | |
dc.identifier.doi | 10.1017/S0033291711001760 | |
dc.identifier.issn | 1469-8978 | |
dc.identifier.issn | 1469-8978 | |
dc.identifier.orcid | Galletly, C. [0000-0001-6185-9677] | |
dc.identifier.orcid | Gill, S. [0000-0001-7180-1807] | |
dc.identifier.uri | http://hdl.handle.net/2440/71825 | |
dc.language.iso | en | |
dc.publisher | Cambridge University Press | |
dc.relation.grant | NHMRC | |
dc.rights | Copyright © Cambridge University Press 2011 | |
dc.source.uri | https://doi.org/10.1017/s0033291711001760 | |
dc.subject | Antidepressant | |
dc.subject | dorsolateral prefrontal cortex | |
dc.subject | high-frequency stimulation | |
dc.subject | neurostimulation | |
dc.subject | treatment service | |
dc.title | A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments? | |
dc.type | Journal article | |
pubs.publication-status | Published |